Skip to main content
Log in

Retrospective analysis of prognostic factors in patients with duodenal adenocarcinoma

  • Original Article
  • Published:
European Surgery Aims and scope Submit manuscript

Summary

Background

Sporadic duodenal cancer is a rare cancer entity. Therefore, the prognostic significance of clinicopathologic features is unknown. This study aimed to identify prognostic factors and compare survival with other tumour entities of the same anatomical region.

Methods

We retrospectively studied medical records of 22 patients with duodenal adenocarcinoma (DAC), who underwent resection in two German centres for pancreatic surgery (1994–2012). Mean time of follow-up was 51.3 months. Predictive factors were evaluated by log rank analysis.

Results

Whipple surgery was performed in seven cases (31.8 %), pylorus preserving pancreaticoduodenectomy in 14 cases (63.6 %) and partial duodenectomy in one case (4.5 %). R0-resection was achieved in 86.4 %. In all, 50% of our patients had nodal positive disease. Overall morbidity was 59.1 % and perioperative mortality was 9.1 %. Survival after resection was 63.6 % and 59.0 % (3- and 5-years). There was no significant survival difference between patients with DAC and ampullary cancer, but survival was longer compared with patients with pancreatic cancer.

Conclusions

Mortality seems to be high after resection of DAC. However, radical surgery should be performed due to the high number of patients with nodal positive disease. No definite prognostic factors were identified. The prognosis after resection of duodenal cancer can be compared with patients with ampullary cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sexe RB, Wade TP, Virgo KS, Johnson FE. Incidence and treatment of periampullary duodenal cancer in the U.S. veteran patient population. Cancer. 1996;77(2):251–4.

    Article  CAS  PubMed  Google Scholar 

  2. Ouriel K, Adams JT. Adenocarcinoma of the small intestine. Am J Surg. 1984;147(1):66–71.

    Article  CAS  PubMed  Google Scholar 

  3. Hurtuk MG, Devata S, Brown KM, Oshima K, Aranha GV, Pickleman J, et al. Should all patients with duodenal adenocarcinoma be considered for aggressive surgical resection? Am J Surg. 2007;193(3):319–24.(discussion 324–5).

    Article  CAS  PubMed  Google Scholar 

  4. Sohn TA, Lillemoe KD, Cameron JL, Pitt HA, Kaufman HS, Hruban RH, et al. Adenocarcinoma of the duodenum: factors influencing long-term survival. J Gastrointest Surg. 1998;2(1):79–87.

    Article  CAS  PubMed  Google Scholar 

  5. Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer. 2004;101(3):518–26.

    Article  PubMed  Google Scholar 

  6. Swartz MJ, Hughes MA, Frassica DA, Herman J, Yeo CJ, Riall TS, et al. Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum. Arch Surg. 2007;142(3):285–8.

    Article  PubMed  Google Scholar 

  7. Santoro E, Sacchi M, Scutari F, Carboni F, Graziano F. Primary adenocarcinoma of the duodenum: treatment and survival in 89 patients. Hepatogastroenterology. 1997;44(16):1157–63.

    CAS  PubMed  Google Scholar 

  8. Kaklamanos IG, Bathe OF, Franceschi D, Camarda C, Levi J, Livingstone AS. Extent of resection in the management of duodenal adenocarcinoma. Am J Surg. 2000;179(1):37–41.

    Article  CAS  PubMed  Google Scholar 

  9. Lee HG, You DD, Paik KY, Heo JS, Choi SH, Choi DW. Prognostic factors for primary duodenal adenocarcinoma. World J Surg. 2008;32(10):2246–52.

    Article  PubMed  Google Scholar 

  10. Lee SY, Lee JH, Hwang DW, Kim SC, Park K-M, Lee Y-J. Long-term outcomes in patients with duodenal adenocarcinoma. ANZ J Surg. 2013.

  11. Han S-L, Cheng J, Zhou H-Z, Zeng Q-Q, Lan S-H. The surgical treatment and outcome for primary duodenal adenocarcinoma. J Gastrointest Cancer. 2010;41(4):243–7.

    Article  PubMed  Google Scholar 

  12. Cecchini S, Correa-Gallego C, Desphande V, Ligorio M, Dursun A, Wargo J, et al. Superior prognostic importance of perineural invasion vs. lymph node involvement after curative resection of duodenal adenocarcinoma. J Gastrointest Surg. 2012;16(1):113–20. (discussion 120).

    Article  PubMed  Google Scholar 

  13. Onkendi EO, Boostrom SY, Sarr MG, Farnell MB, Nagorney DM, Donohue JH, et al. 15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas. J Gastrointest Surg. 2012;16(4):682–91.

    Article  PubMed  Google Scholar 

  14. Malleo G, Tonsi A, Marchegiani G, Casarotto A, Paiella S, Butturini G, et al. Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma. Langenbecks Arch Surg. 2013;398(2):287–94.

    Article  PubMed  Google Scholar 

  15. Struck A, Howard T, Chiorean EG, Clarke JM, Riffenburgh R, Cardenes HR. Non-ampullary duodenal adenocarcinoma: factors important for relapse and survival. J Surg Oncol. 2009;100(2):144–8.

    Article  PubMed  Google Scholar 

  16. Rose DM, Hochwald SN, Klimstra DS, Brennan MF. Primary duodenal adenocarcinoma: a ten-year experience with 79 patients. J Am Coll Surg. 1996;183(2):89–96.

    CAS  PubMed  Google Scholar 

  17. Sarela AI, Brennan MF, Karpeh MS, Klimstra D, Conlon KCP. Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer. Ann Surg Oncol. 2004;11(4):380–6.

    Article  PubMed  Google Scholar 

  18. Distler M, Rückert F, Hunger M, Kersting S, Pilarsky C, Saeger H-D, et al. Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma. BMC Surg. 2013;13:12.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Rückert F, Kersting S, Fiedler D, Distler M, Dobrowolski F, Pilarsky C, et al. Chronic pancreatitis: early results of pancreatoduodenectomy and analysis of risk factors. Pancreas. 2011;40(6):925–30.

    Article  PubMed  Google Scholar 

  20. Wente MN, Veit JA, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery. 2007;142(1):20–5.

    Article  PubMed  Google Scholar 

  21. Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2007;142(5):761–8.

    Article  PubMed  Google Scholar 

  22. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138(1):8–13.

    Article  PubMed  Google Scholar 

  23. Kleinerman J, Yardumian K, Tamaki H. Primary carcinoma of the duodenum. Ann Intern Med. 1950;32:451–65.

    Article  Google Scholar 

  24. Sarma DP, Weilbaecher TG. Adenocarcinoma of the duodenum. J Surg Oncol. 1987;34(4):262–3.

    Article  CAS  PubMed  Google Scholar 

  25. Rückert F, Pilarsky C, Grützmann R. Serum tumor markers in pancreatic cancer-recent discoveries. Cancers (Basel). 2010;2(2):1107–24.

    Article  Google Scholar 

  26. Grützmann R, Rückert F, Hippe-Davies N, Distler M, Saeger H-D. Evaluation of the International Study Group of Pancreatic Surgery definition of post-pancreatectomy hemorrhage in a high-volume center. Surgery. 2012;151(4):612–20.

    Article  PubMed  Google Scholar 

  27. Allema JH, Reinders ME, van Gulik TM, Koelemay MJ, Van Leeuwen DJ, de Wit LT, et al. Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer. 1995;75(8):2069–76.

    Article  CAS  PubMed  Google Scholar 

  28. Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P, et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg. 2001;234(6):758–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Jabbour SK, Mulvihill D. Defining the role of adjuvant therapy: ampullary and duodenal adenocarcinoma. Semin Radiat Oncol. 2014;24(2):85–93.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Téoule.

Additional information

P. Téoule and M. Distler contributed equally.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Téoule, P., Distler, M., Niedergethmann, M. et al. Retrospective analysis of prognostic factors in patients with duodenal adenocarcinoma. Eur Surg 48, 228–234 (2016). https://doi.org/10.1007/s10353-015-0374-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10353-015-0374-0

Keywords

Navigation